In the United States, OA of the knee affects 9.3 million adults over the age of 45 years. As severity of pain and dysfunction increases, and conservative measures fail, surgery becomes an option. ABS OrthoGlide is a minimally invasive surgical alternative for many individuals with severe OA of the knee.

ABS has developed a cobalt-chrome implant with a unique and innovative design. The ABS OrthoGlide replaces the cartilage lost in the osteoarthritic knee.

The implant's unique engineering provides positional stability without the use of rigid fixation or bone removal. In addition, the specially contoured geometry provides an open glide path, allowing for the unconstrained motion of the femoral condyle.

OrthoGlide is an FDA cleared, bone sparing alternative for many individuals facing surgery for debilitating osteoarthritis of the knee.

If you are interested in receiving additional information about ABS Corporation or the company’s products, please contact us.